首页 > 市场调查报告书 > 製药

再生医学

市场调查报告书

商品编码

1467705

2024-2032 年按产品类型、服务类型、银行类型、利用率、应用和地区分類的干细胞银行市场报告

Stem Cell Banking Market Report by Product Type, Service Type, Bank Type, Utilization, Application, and Region 2024-2032

出版日期: 2024年04月08日 | 出版商:

IMARC | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

2023年，全球IMARC Group细胞银行市场规模达到80亿美元。干细胞分离、储存和运输技术的不断进步、医疗保健支出的不断增加、再生医学的不断进步以及私人公司的大量投资是推动市场发展的一些因素。

干细胞银行是一项革命性的医学进步，为未来提供了一条生命线。这个过程涉及保存各种来源的干细胞，例如脐带血或成人组织。这些细胞具有显着的再生潜力，是治疗从白血病到帕金森氏症等神经退化性疾病等多种疾病的关键。干细胞库透过在超低温下低温冷冻这些生物宝藏来保护它们，确保其存活数十年。其影响是深远的。家庭可以获得生物保险，因为这些细胞可以治疗捐赠者和遗传相容的亲属，从而降低免疫排斥的风险。此外，干细胞研究不断推出新的治疗应用，并有望在个人化医疗方面取得突破。然而，可及性仍然是一个问题，全球的成本和意识各不相同。干细胞银行是一项富有远见的健康投资。它可以开启一个用患者的细胞治疗衰弱性疾病的未来，消除对高风险移植的需要，并开启医学科学的新领域。扩大这种变革性技术的获取和认识对于充分发挥其潜力造福人类至关重要。

全球市场的主要动力是人们对干细胞在治疗癌症、糖尿病和心血管疾病等多种疾病方面的治疗潜力的认识不断提高。广泛的研究和临床试验不断证明干细胞疗法的功效，激发了医学专业人士和公众的想像力，从而推动了这种认识的提升。此外，随着越来越多的夫妇选择晚育，延迟生育的趋势不断扩大，这增强了人们对脐带血库的兴趣。父母认识到保存新生儿脐带血干细胞作为生物保险的价值，以防他们的孩子或家庭成员面临未来的医疗挑战。此外，干细胞银行服务的全球化是另一个关键驱动力。冷冻保存技术的进步延长了储存的干细胞的保质期，从而可以进行国际运输和跨境利用。这扩大了市场范围并促进了干细胞库之间的全球合作。此外，政府支持和监管框架变得更有利于干细胞银行业务，为投资和成长创造有利的环境。慢性疾病的日益普及以及干细胞提供个人化治疗的潜力巩固了其作为未来医疗保健关键组成部分的地位，确保了市场的持续扩张。

干细胞银行市场趋势/驱动因素：

人口老化加剧

人口老化的加剧对市场有正面影响。这种人口结构的变化正在改变全球的医疗保健动态。随着年龄的增长，他们变得更容易患骨关节炎、心血管疾病等退化性疾病，以及阿兹海默症和帕金森氏症等神经退化性疾病。干细胞在再生受损或老化组织方面具有巨大前景，为突破性治疗和提高老年人的生活品质提供了潜力。不断增长的老年人口需要更先进的医疗保健解决方案，并且代表了干细胞银行服务的庞大客户群。一些个人和家庭认识到保存从脐带血或脂肪组织等来源采集的干细胞的潜力。这些储存的干细胞可用于未来的治疗，以对抗与年龄相关的健康问题，创造安全感和乐观感。因此，老龄化人口对干细胞再生潜力的认识不断增强，加上他们对改善医疗保健选择的渴望，是干细胞银行服务需求不断增长的驱动力，为未来几年的持续增长奠定了基础。

临床试验的接受度不断提高

对临床试验的接受度不断提高正在刺激市场。临床试验对于证明干细胞疗法在各种疾病（从癌症到脊髓损伤）的安全性和有效性至关重要。随着这些试验的结果继续显示出希望，医疗专业人员、研究人员和公众对基于干细胞的治疗的信心得到增强。这种日益增长的接受度意味着对干细胞银行服务的更大需求。临床试验通常需要易于取得且可靠的高品质干细胞来源，而专门储存这些细胞的银行可以满足这一关键需求。研究人员和製药公司依靠这些银行提供试验所需的标准化且保存完好的干细胞样本，从而推动市场的成长。此外，临床试验的积极成果推动了再生医学领域的发展，吸引了公共和私营部门的投资，促进创新并扩大干细胞银行服务的范围。这种研究、接受度和投资的良性循环推动着市场。

围绕胚胎干细胞使用的伦理担忧不断升级

围绕胚胎干细胞的使用不断升级的道德担忧正在提振市场。由于破坏胚胎，胚胎干细胞研究长期以来一直是伦理争论的主题，导致许多地区受到道德和监管限制。这使得干细胞研究和治疗应用的重点转向了无争议的来源，例如成体干细胞和脐带血。因此，寻求干细胞疗法潜在益处且不受道德困境的个人和机构正在转向干细胞银行。尤其是脐带血，作为干细胞的丰富来源而受到关注，而且没有任何伦理问题。家庭和医疗保健提供者认识到保存这些细胞作为生物保险的价值，为捐赠者和可能相容的家庭成员预防未来的疾病。这种向道德上合理的干细胞来源的转变符合大多数干细胞库的做法，吸引了更广泛的客户群并为行业的成长做出了贡献。由于道德考量继续影响公众舆论和监管决策，市场处于持续扩张的有利位置。

The global stem cell banking market size reached US$ 8.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.8 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032. The increasing improvements in stem cell isolation, storage, and transportation technologies, the rising healthcare expenditure, the growing progress in regenerative medicine, and the heavy investments by private companies are some of the factors propelling the market.

Stem cell banking, a revolutionary medical advancement, offers a lifeline for the future. This process involves preserving stem cells from various sources, such as umbilical cord blood or adult tissues. These cells possess remarkable regenerative potential, holding the key to treating multiple diseases, from leukemia to neurodegenerative conditions like Parkinson's. Stem cell banking safeguards these biological treasures by cryogenically freezing them at ultra-low temperatures, ensuring their viability for decades. The implications are profound. Families can secure a biological insurance policy, as these cells can treat the donor and genetically compatible relatives, reducing the risk of immune rejection. Additionally, stem cell research continues to unveil new therapeutic applications, promising breakthroughs in personalized medicine. However, accessibility remains an issue, with costs and awareness varying globally. Stem cell banking is a visionary investment in health. It can unlock a future where debilitating diseases are treated with the patient's cells, eliminating the need for risky transplants and opening new frontiers in medical science. Expanding access and awareness of this transformative technology is essential to harness its full potential for the benefit of humanity.

The global market is majorly driven by increasing awareness of the therapeutic potential of stem cells in treating a wide array of diseases, including cancer, diabetes, and cardiovascular conditions. This heightened awareness is fueled by extensive research and clinical trials that continually demonstrate the efficacy of stem cell-based therapies, capturing the imagination of medical professionals and the general public. Furthermore, the expanding trend of delayed parenthood, with more couples opting to have children later in life, has intensified interest in umbilical cord blood banking. Parents recognize the value of preserving their newborn's cord blood stem cells as biological insurance should their child or a family member face a future medical challenge. Moreover, the globalization of stem cell banking services is another key driver. Advances in cryopreservation techniques have extended the shelf life of stored stem cells, allowing for international transportation and cross-border utilization. This has widened the market's reach and fostered worldwide collaboration among stem cell banks. Additionally, government support and regulatory frameworks are becoming more conducive to stem cell banking, fostering a favorable environment for investment and growth. The increasing prevalence of chronic diseases and the potential of stem cells to provide personalized treatments solidifies its position as a pivotal component of future healthcare, ensuring the market's continued expansion.

Stem Cell Banking Market Trends/Drivers:

Increasing aging population

The increasing aging population is positively influencing the market. This demographic shift is transforming healthcare dynamics globally. As individuals age, they become more susceptible to degenerative diseases such as Osteoarthritis, cardiovascular conditions, and neurodegenerative disorders like Alzheimer's and Parkinson's. Stem cells hold immense promise in regenerating damaged or aging tissues, offering the potential for groundbreaking treatments and enhanced quality of life for older people. This growing elderly population demands more advanced healthcare solutions and represents a substantial customer base for stem cell banking services. Several individuals and families recognize the potential of preserving their or their loved ones' stem cells, harvested from sources like cord blood or adipose tissue. These stored stem cells can be used in future therapies to combat age-related health issues, creating a sense of security and optimism. As a result, the aging population's increasing awareness of the regenerative potential of stem cells, coupled with their desire for improved healthcare options, is a driving force behind the rising demand for stem cell banking services, positioning the market for sustained growth in the years to come.

Rising acceptance of clinical trials

The rising acceptance of clinical trials is catalyzing the market. Clinical trials are pivotal in demonstrating the safety and efficacy of stem cell-based therapies across various medical conditions, ranging from cancer to spinal cord injuries. As the results of these trials continue to show promise, confidence in stem cell-based treatments is bolstered among medical professionals, researchers, and the general public. This increasing acceptance translates into greater demand for stem cell banking services. Clinical trials often require a readily accessible and reliable source of high-quality stem cells, and banks specializing in storing these cells meet this critical need. Researchers and pharmaceutical companies rely on these banks to provide the standardized and well-preserved stem cell samples required for their trials, thus driving the market's growth. Furthermore, positive outcomes from clinical trials advance the regenerative medicine field and attract investments from both the public and private sectors, fostering innovation and expanding the range of stem cell banking services available. This virtuous cycle of research, acceptance, and investment propels the market.

Escalating ethical concerns surrounding the use of embryonic stem cells

The escalating ethical concerns surrounding the use of embryonic stem cells are bolstering the market. Embryonic stem cell research has long been a subject of ethical debate due to destroying embryos, resulting in moral and regulatory restrictions in many regions. This has shifted the focus of stem cell research and therapeutic applications towards non-controversial sources, such as adult stem cells and cord blood. As a result, individuals and institutions seeking the potential benefits of stem cell therapies without ethical quandaries are turning to stem cell banking. Cord blood, in particular, has gained prominence as a rich source of stem cells without any ethical concerns. Families and healthcare providers recognize the value of preserving these cells as biological insurance against future illnesses for the donor and potentially compatible family members. This shift towards ethically sound stem cell sources aligns with the practices of most stem cell banks, attracting a broader customer base and contributing to the industry's growth. The market is well-positioned for sustained expansion as ethical considerations continue influencing public opinion and regulatory decisions.

Stem Cell Banking Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product type, service type, bank type, utilization and application.

Breakup by Product Type:

Adult Stem Cells

Human Embryonic Cells

IPS Cells

Adult stem cells dominate the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes adult stem cells, human embryonic cells, and IPS cells. According to the report, adult stem cells represented the largest segment.

Adult stem cells, also known as somatic or tissue-specific, have emerged as a game-changer in regenerative medicine. These cells are ethically uncontroversial, sourced from bone marrow, adipose tissue, and peripheral blood. Their therapeutic potential in treating various ailments, including orthopedic issues, cardiovascular diseases, and autoimmune disorders, is increasingly recognized.

The rising demand for adult stem cell banking services stems from the growing awareness of their versatility and effectiveness. Patients, physicians, and researchers are considering preserving adult stem cells as a proactive approach to future medical challenges. This demand drives competition and innovation within the industry, resulting in improved storage techniques and expanded service offerings. As regenerative medicine continues to advance, the adult stem cell segment stands as a linchpin in the market's overall expansion, promising personalized healthcare solutions for various conditions and securing its position at the forefront of medical progress.

Breakup by Service Type:

Sample Preservation and Storage

Sample Analysis

Sample Processing

Sample Collection and Transportation

Sample preservation and storage dominate the market

The report has provided a detailed breakup and analysis of the market based on the service type. This includes sample preservation and storage, sample analysis, sample processing, and sample collection and transportation. According to the report, sample preservation and storage represented the largest segment.

Sample preservation and storage segment plays a pivotal role in propelling the market. Stem cell therapies have emerged as a revolutionary medical frontier, promising treatments for various diseases and conditions. Consequently, the demand for safe and reliable storage solutions for precious stem cell samples has skyrocketed. These services offered by stem cell banks ensure these valuable biological assets' long-term viability and potency. This crucial service segment encompasses cutting-edge cryopreservation techniques, state-of-the-art storage facilities, and rigorous quality control measures.

In an era where regenerative medicine is gaining prominence, the efficacy of stem cell treatments hinges on the integrity and accessibility of stored samples. The commitment of stem cell banks to maintaining optimal sample conditions instills confidence in healthcare providers and encourages individuals to invest in stem cell banking for their future medical needs. This rising demand for Sample Preservation and Storage services drives the revenue growth of stem cell banks and fuels advancements in biotechnology and medical research, ultimately paving the way for innovative therapies and improved healthcare outcomes.

Breakup by Bank Type:

Private

Public

Private dominates the market

The report has provided a detailed breakup and analysis of the market based on the bank type. This includes private and public. According to the report, private represented the largest segment.

Private stem cell banks cater to the growing trend of individuals and families taking proactive measures to secure their health and that of their loved ones. These banks offer a unique opportunity for clients to preserve their own or their newborn's stem cells, often sourced from cord blood, for potential future medical needs. This personalized approach to healthcare resonates strongly with a wide demographic, ranging from expectant parents seeking to secure their child's health to adults considering their long-term well-being.

The appeal of private stem cell banks lies in the assurance of access and control over one's biological assets a sense of biological insurance. As medical research unveils novel therapies and applications for stem cells, private banks' convenience and peace of mind are significant drivers of market growth. This segment's emphasis on personalized healthcare aligns with the evolving healthcare landscape, cementing its role in shaping the future of medicine and propelling market growth.

Breakup by Utilization:

Used

Unused

Unused dominates the market

The report has provided a detailed breakup and analysis of the market based on the utilization. This includes used and unused. According to the report, unused represented the largest segment.

The unused segment is equally influential, especially with the growing trend toward proactive healthcare. Individuals and families recognize the intrinsic value of preserving stem cells for potential future use, even without immediate medical need. This preventive approach is reinforced by ongoing research revealing new applications for stem cells. The prospect of securing biological insurance against unforeseen health challenges or benefiting from emerging therapies amplifies the demand for stem cell banking services, further solidifying its position as a dynamic force in modern healthcare.

Furthermore, the used segment reflects the escalating clinical adoption of stem cell-based therapies and treatments, spanning various medical conditions from leukemia to spinal cord injuries. As the effectiveness and safety of these therapies become increasingly established through clinical trials and real-world applications, the demand for access to stored stem cell samples surges. This drives the growth of stem cell banking services as patients and healthcare providers seek reliable sources for viable and high-quality stem cells.

Breakup by Application:

Personalized Banking Applications

Research Applications

Clinical Applications

Clinical applications dominate the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes personalized banking applications, research applications, and clinical applications. According to the report, clinical applications represented the largest segment.

Stem cells hold immense potential in regenerative medicine, and clinical applications harness this potential to treat various medical conditions. From neurological disorders like Parkinson's and Alzheimer's to orthopedic injuries and autoimmune diseases, stem cell-based therapies offer new hope for patients worldwide. The availability of well-preserved and diverse stem cell samples from banks is paramount for successful clinical interventions.

Clinical applications encompass established treatments and cutting-edge therapies in various stages of development, including clinical trials. These applications demand various stem cell types, such as hematopoietic, mesenchymal, and induced pluripotent stem cells, each tailored to specific medical needs. Stem cell banks offering a comprehensive array of these resources contribute significantly to the growth of clinical applications in regenerative medicine.

Furthermore, as research expands our understanding of stem cell biology and therapeutic potential, the clinical landscape is poised for continuous evolution. Consequently, the Clinical Applications segment remains a key driver in the stem cell banking market, fostering innovation and offering renewed optimism for patients seeking novel treatments and improved healthcare outcomes.

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

North America exhibits a clear dominance, accounting for the largest market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.

North America plays a pivotal role in driving the growth of the market. With its advanced healthcare infrastructure, robust research and development activities, and a population increasingly aware of the potential benefits of stem cell therapies, the region stands at the forefront of this burgeoning industry. In the region, stem cell banking is viewed as a proactive health measure and a source of hope for patients suffering from a range of debilitating conditions.

In particular, the United States and Canada have witnessed significant investments in private stem cell banks driven by a combination of healthcare advancements and a culture of health-consciousness. Furthermore, the region's regulatory environment has been relatively supportive, further bolstering market growth by fostering a favorable climate for stem cell banking services.

As clinical trials for stem cell-based therapies expand, and research endeavors continue to flourish in North America, the demand for high-quality stem cell preservation and banking services continues to rise, making this region a powerhouse in shaping the future of stem cell banking.

Competitive Landscape:

Top companies are pivotal in strengthening market growth through a multifaceted approach. These industry leaders invest heavily in cutting-edge research and development, driving innovation in stem cell preservation and analysis techniques. They continually enhance the quality and viability of stored stem cells, instilling confidence in their clients and the medical community. These companies also prioritize extensive collaborations with research institutions, pharmaceutical firms, and healthcare providers. This collaborative spirit fosters the advancement of stem cell-based therapies, expanding their applications and creating a growing demand for banking services. Moreover, top firms actively engage in public awareness campaigns, educating individuals and families about the potential benefits of stem cell banking. This outreach grows the customer base and fuels interest in stem cell research and regenerative medicine. Additionally, their international presence and ability to provide cross-border services amplify market reach and accessibility, further driving growth.

The report has provided a comprehensive analysis of the competitive landscape in the stem cell banking market. Detailed profiles of all major companies have also been provided.

CBR Systems Inc.

China Cord Blood Corporation

Cordlife

Cordvida

Cryo-Cell International, Inc.

Cryo-Save AG (A Group of Esperite)

Cryoviva India

Lifecell

Smart Cells International Ltd

Viacord

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

In July 2023, Cordlife announced advanced research on Mesenchymal Stem Cell Secretome-based products for treating Osteoarthritis.

In March 2022, Cryo-Cell International, Inc. revealed its acquisition of a 56,000-square-foot facility in the Research Triangle, North Carolina, within the Regional Commerce Center. This acquisition is contingent upon the fulfillment of standard closing conditions.

Key Questions Answered in This Report

1. What was the size of the global stem cell banking market in 2023?
2. What is the expected growth rate of the global stem cell banking market during 2024-2032?
3. What are the key factors driving the global stem cell banking market?
4. What has been the impact of COVID-19 on the global stem cell banking market?
5. What is the breakup of the global stem cell banking market based on the product type?
6. What is the breakup of the global stem cell banking market based on the service type?
7. What is the breakup of the global stem cell banking market based on the bank type?
8. What is the breakup of the global stem cell banking market based on the utilization?
9. What is the breakup of the global stem cell banking market based on the application?
10. What are the key regions in the global stem cell banking market?
11. Who are the key players/companies in the global stem cell banking market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Stem Cell Banking Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Product Type
5.5 Market Breakup by Service Type
5.6 Market Breakup by Bank Type
5.7 Market Breakup by Utilization
5.8 Market Breakup by Application
5.9 Market Breakup by Region
5.10 Market Forecast

6 Market Breakup by Product Type

6.1 Adult Stem Cells
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Human Embryonic Cells
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 IPS Cells
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Service Type

7.1 Sample Preservation and Storage
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Sample Analysis
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Sample Processing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Sample Collection and Transportation
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Bank Type

8.1 Private
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Public
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Utilization

9.1 Used
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Unused
- 9.2.1 Market Trends
- 9.2.2 Market Forecast

10 Market Breakup by Application

10.1 Personalized Banking Applications
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Research Applications
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Clinical Applications
- 10.3.1 Market Trends
- 10.3.2 Market Forecast

11 Market Breakup by Region

11.1 North America
- 11.1.1 Market Trends
- 11.1.2 Market Forecast
11.2 Europe
- 11.2.1 Market Trends
- 11.2.2 Market Forecast
11.3 Asia Pacific
- 11.3.1 Market Trends
- 11.3.2 Market Forecast
11.4 Middle East and Africa
- 11.4.1 Market Trends
- 11.4.2 Market Forecast
11.5 Latin America
- 11.5.1 Market Trends
- 11.5.2 Market Forecast

12 Global Stem Cell Banking Industry: SWOT Analysis

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Global Stem Cell Banking Industry: Value Chain Analysis

14 Global Stem Cell Banking Industry: Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Global Stem Cell Banking Industry: Price Analysis

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
- 16.3.1 CBR Systems Inc.
- 16.3.2 China Cord Blood Corporation
- 16.3.3 Cordlife
- 16.3.4 Cordvida
- 16.3.5 Cryo-Cell International, Inc.
- 16.3.6 Cryo-Save AG (A Group of Esperite)
- 16.3.7 Cryoviva India
- 16.3.8 Lifecell
- 16.3.9 Smart Cells International Ltd
- 16.3.10 Viacord

简介目录图表

List of Figures

Figure 1: Global: Stem Cell Banking Market: Major Drivers and Challenges
Figure 2: Global: Stem Cell Banking Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Stem Cell Banking Market: Breakup by Product Type (in %), 2023
Figure 4: Global: Stem Cell Banking Market: Breakup by Service Type (in %), 2023
Figure 5: Global: Stem Cell Banking Market: Breakup by Bank Type (in %), 2023
Figure 6: Global: Stem Cell Banking Market: Breakup by Utilization (in %), 2023
Figure 7: Global: Stem Cell Banking Market: Breakup by Application (in %), 2023
Figure 8: Global: Stem Cell Banking Market: Breakup by Region (in %), 2023
Figure 9: Global: Stem Cell Banking Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 10: Global: Stem Cell Banking Industry: SWOT Analysis
Figure 11: Global: Stem Cell Banking Industry: Value Chain Analysis
Figure 12: Global: Stem Cell Banking Industry: Porter's Five Forces Analysis
Figure 13: Global: Stem Cell Banking (Adult Stem Cells) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Stem Cell Banking (Adult Stem Cells) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Stem Cell Banking (Human Embryonic Cells) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Stem Cell Banking (Human Embryonic Cells) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Stem Cell Banking (IPS Cells) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Stem Cell Banking (IPS Cells) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Stem Cell Banking (Sample Preservation and Storage) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Stem Cell Banking (Sample Preservation and Storage) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Stem Cell Banking (Sample Analysis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Stem Cell Banking (Sample Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Stem Cell Banking (Sample Processing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Stem Cell Banking (Sample Processing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Stem Cell Banking (Sample Collection and Transportation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Stem Cell Banking (Sample Collection and Transportation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Stem Cell Banking (Private) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Stem Cell Banking (Private) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Stem Cell Banking (Public) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Stem Cell Banking (Public) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Stem Cell Banking (Used) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Stem Cell Banking (Used) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Stem Cell Banking (Unused) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Stem Cell Banking (Unused) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Stem Cell Banking (Personalized Banking Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Stem Cell Banking (Personalized Banking Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Stem Cell Banking (Research Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Stem Cell Banking (Research Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Global: Stem Cell Banking (Clinical Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Global: Stem Cell Banking (Clinical Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: North America: Stem Cell Banking Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: North America: Stem Cell Banking Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Europe: Stem Cell Banking Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Europe: Stem Cell Banking Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Asia Pacific: Stem Cell Banking Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Asia Pacific: Stem Cell Banking Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Middle East and Africa: Stem Cell Banking Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Middle East and Africa: Stem Cell Banking Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Latin America: Stem Cell Banking Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Latin America: Stem Cell Banking Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

Table 1: Global: Stem Cell Banking Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Stem Cell Banking Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
Table 3: Global: Stem Cell Banking Market Forecast: Breakup by Service Type (in Million US$), 2024-2032
Table 4: Global: Stem Cell Banking Market Forecast: Breakup by Bank Type (in Million US$), 2024-2032
Table 5: Global: Stem Cell Banking Market Forecast: Breakup by Utilization (in Million US$), 2024-2032
Table 6: Global: Stem Cell Banking Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 7: Global: Stem Cell Banking Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 8: Global: Stem Cell Banking Market Structure
Table 9: Global: Stem Cell Banking Market: Key Players

02-2729-4219

+886-2-2729-4219

License/价格

2024-2032 年按产品类型、服务类型、银行类型、利用率、应用和地区分類的干细胞银行市场报告

Stem Cell Banking Market Report by Product Type, Service Type, Bank Type, Utilization, Application, and Region 2024-2032

干细胞银行市场趋势/驱动因素：

目录

第一章：前言

第 2 章：范围与方法

第 3 章：执行摘要

第 4 章：简介

第 5 章：全球干细胞银行市场

第 6 章：市场区隔：依产品类型

第 7 章：市场区隔：按服务类型

第 8 章：市场区隔：依银行类型

第 9 章：市场区隔：按利用率

第 10 章：市场区隔：按应用

第 11 章：市场区隔：按地区

第 12 章：全球干细胞银行业：SWOT 分析

第 13 章：全球干细胞银行产业：价值链分析

第 14 章：全球干细胞银行业：波特五力分析

第 15 章：全球干细胞银行产业：价格分析

第16章：竞争格局